Pathstone Family Office’s CME Group CME Stock Holding History
Bought
Maintained
Sold
Other funds holding CME
Pathstone Family Office's CME Position: Q3 2023 in Review
Pathstone Family Office increased its CME Group (CME) stake by 107% in Q3 2023, buying an estimated $1.95M and bringing the position to 18,985 shares worth $3.8M. The position accounts for 0.03% of the portfolio, ranked #331.
Pathstone Family Office first reported a position in CME in Q1 2017 and has held it in 21 quarters since. The position peaked at $4.95M in Q3 2022. 1,229 funds tracked by Wall St. Rank hold CME as of Q3 2023.
- Pathstone Family Office held 18,985 shares of CME Group worth $3.8M as of Q3 2023.
- Pathstone Family Office bought 9,806 CME Group shares in Q3 2023, an estimated $1.95M.
- CME Group made up 0.03% of Pathstone Family Office's portfolio in Q3 2023, its #331 holding.
- Pathstone Family Office first reported a position in CME Group in Q1 2017 and has held it in 21 quarters since.
- Pathstone Family Office's CME Group position peaked at $4.95M in Q3 2022.
- 1,229 funds tracked by Wall St. Rank held CME Group as of Q3 2023.
Based on Pathstone Family Office's 13F filing for Q3 2023, filed 8 Nov 2023.